A monthly medication price does not explain who will evaluate you, where a prescription will go or whom to call when treatment raises a question. Slim Wellness Center offers more detail about those responsibilities than an anonymous enrollment page: it identifies a nurse practitioner who conducts patient visits, a physician medical director and a pharmacy source. The important distinction is that naming the participants does not fully document how every handoff works, particularly for its California-only telehealth tirzepatide option.
This review follows that care pathway using public documentation consulted October 19, 2026. Slim describes itself as a small, physician-supervised medical wellness clinic in National City, California, and advertises semaglutide and tirzepatide programs when clinically appropriate. Its local service model is relatively tangible, with an address, office hours and periodic visits. The remote pathway leaves more practical questions unanswered. Credentials, pharmacy verification and certification discussed here are the clinic’s representations, not independently verified findings.
At a glance
- Treating clinician
- Slim says nurse practitioner Lyan Love McCullough handles consultations, treatment planning and follow-up for every patient; Dr. Gidon Akler oversees clinical protocols.Sources: [4]
- Published tirzepatide prices
- The clinic advertises $179/month in clinic or $200/month through telehealth, for California patients only. All prescribed dose levels, consultations and necessary supplies are included; in-clinic care also includes a 3D scan.Sources: [3]
- Initial access
- No referral is required. Patients can start with an online questionnaire or call (619) 765-4141, followed by a medical evaluation.
- Named pharmacy source
- Slim identifies Integrity Compounding Pharmacy in Sandy Springs, Georgia, as its medication source. This does not independently verify the pharmacy or establish each patient’s dispensing arrangements.Sources: [9]
- Commercial-document limitation
- The consulted terms-of-service address displayed a privacy policy, leaving renewal, cancellation and refund conditions unestablished in the reviewed documentation.Sources: [8]
Start with the clinician, not just the enrollment form
Slim assigns patient-facing care to Lyan Love McCullough, whom it identifies as a nurse practitioner. The site says she handles consultations, treatment planning, dosing decisions and follow-ups for every patient, presenting continuity with the same clinician as part of its model. That is more specific than a general promise of medical supervision. It also means readers should not interpret the physician-supervised description as a promise that a physician conducts their routine appointments.
The clinic identifies Dr. Gidon Akler as medical director, responsible for establishing and supervising clinical protocols, while McCullough conducts visits. It attributes training in Pediatrics and Medical Genetics at Mount Sinai Hospital in New York and board certification in Medical Genetics and Genomic Medicine to Akler. These are provider-stated credentials; this review did not independently verify them. The distinction between a treating clinician and a supervising medical director matters when deciding where to direct treatment questions.
A useful first conversation would establish who covers absences, how a patient reaches the treating clinician between appointments and whether the same-provider arrangement also applies to telehealth. The public documentation does not establish those operational details. Our guide to clinician and platform responsibilities explains why the organization accepting an enrollment, the professional making clinical decisions and the pharmacy dispensing medication should be understood as separate responsibilities, even when a service coordinates all three.
The questionnaire opens the process; the evaluation determines the plan
The advertised 60-second questionnaire asks about goals and health history. That timing describes an introductory form, not a complete medical evaluation or a prescription decision. Slim says qualification depends on health history, BMI, current medications and goals, followed by evaluation with its provider. No referral is needed: prospective patients can use the online questionnaire or telephone the clinic to arrange an appointment. Its privacy policy describes the website and services as intended for adults 18 and older.
Every program, according to the clinic, begins with a medical evaluation covering history, goals and laboratory work when needed. The consulted material does not specify a mandatory laboratory panel or publish exact BMI thresholds for the GLP-1 program. It also does not establish whether an existing set of laboratory results will be accepted. These are practical intake questions because they affect both the steps before treatment and potentially the cost beyond the expressly listed program inclusions.
Slim’s safety page lists exclusions including personal or family history of medullary thyroid carcinoma, MEN 2, serious allergy to the product or its ingredients, pregnancy, planned pregnancy and breastfeeding. This describes the clinic’s published screening boundaries, not an individualized eligibility decision. Preparing medication, supplement and health-history information is more useful than treating a short questionnaire as approval. Our first-consultation preparation guide provides a framework for organizing that conversation without attempting to select treatment yourself.
The local clinic pathway is more concrete than the remote one
The published office is at 655 Euclid Ave #210, National City, CA 91950. Slim lists service to National City, Chula Vista, Paradise Hills, Bonita, Imperial Beach and the greater San Diego area. Its contact page gives Monday through Friday hours of 9:00 a.m. to 6:00 p.m., with Saturday and Sunday closed. It also states that free parking is available near the entrance and that the building is fully accessible.
For in-person treatment, the site describes an initial evaluation followed by periodic check-ins and injections depending on the program, with a schedule arranged for the patient. The advertised in-clinic tirzepatide package adds a 3D scan. This establishes a physical setting and a broad follow-up pattern, but not a universal visit frequency or a precise description of which medication services happen during every appointment. Those details should be confirmed for the proposed plan rather than inferred from general clinic language.
The telehealth option is advertised for California patients, not as a nationwide program. However, other site language emphasizes starting care at the clinic, and the consulted documentation does not fully reconcile that description with remote enrollment. Before paying for telehealth, ask whether any in-person visit is required, how the evaluation occurs and whether medication is collected or delivered. The remote price alone does not establish an entirely home-based pathway from first assessment through subsequent supplies.
What the monthly price includes—and what it does not explain
Slim publishes tirzepatide at $179 per month in clinic or $200 per month through telehealth, for California patients only. The advertised inclusions are all prescribed dose levels, consultations and necessary supplies, plus a 3D scan for the in-clinic program. The documentation does not identify the exact formulation, brand, route, presentation or quantity dispensed under that price. General references to injections elsewhere do not resolve those product details for every program.
The site also advertises semaglutide, but does not publish its price in the consulted material. For other medications, Slim says it will explain exact pricing before a commitment. Laboratory charges and possible items outside the express tirzepatide inclusions remain unclear. Insurance acceptance, medication coverage and assistance with prior authorization are also not established. A prospective patient therefore needs a written description of the proposed product and services, not just confirmation of the headline monthly amount.
Cherry financing and CareCredit are offered as ways to divide treatment costs into monthly payments. These are payment alternatives, not evidence that financing approval is guaranteed or that treatment requires upfront prepayment. Applications go directly through those companies under their own privacy policies. Separately, the reviewed pages do not explain automatic billing, minimum commitments, renewal dates, cancellation or refunds. The terms-of-service address displayed a privacy policy rather than commercial terms, so those boundaries require direct clarification.
| Care or payment item | What Slim publishes | What to confirm |
|---|---|---|
| In-clinic tirzepatide | $179/month; California patients only | Exact product, presentation, quantity and billing dates |
| Telehealth tirzepatide | $200/month; California patients only | Remote-visit process and any required clinic attendance |
| Included services | All prescribed dose levels, consultations and necessary supplies; in-clinic 3D scan | Laboratory charges and any separately billed services |
| Other medications | Exact pricing discussed before commitment | Semaglutide price and itemized inclusions |
| Payment alternatives | Cherry financing and CareCredit | Financing terms separately from clinic renewal and cancellation rules |
A named pharmacy is a starting point, not a complete fulfillment policy
Slim identifies Integrity Compounding Pharmacy as its medication source and lists 8601 Dunwoody Place, Suite 750, Sandy Springs, GA 30350, with telephone number 404-815-1610. The clinic also describes itself as LegitScript approved and labels the pharmacy relationship as verified. These are claims on the clinic’s site, not independent verification performed for this review. Nor does naming a compounding pharmacy establish who prepares or dispenses every specific product a patient might receive.
The site says compounded medications are prescribed at a licensed provider’s discretion when clinically appropriate and after medical evaluation. If a treatment plan involves a compounded preparation, Slim says the provider will discuss its source and implications directly. That discussion should identify the actual prescription, formulation, route and dispensing pharmacy. Our pharmacy-handoff guide explains the questions that connect a clinical decision to the labeled product a patient ultimately receives.
Fulfillment is one of the largest documentary gaps. The consulted pages do not establish preparation time, shipping charges, cold-chain arrangements, dispatch or arrival estimates, or a pickup procedure for telehealth patients. A monthly price does not establish a specific quantity of medicine or supply interval. Before enrollment, ask who communicates delays, who resolves a missing or damaged shipment and which party gives product-handling instructions. The existence of a pharmacy address does not answer those service questions.
Compounding disclosures need a product-specific conversation
Slim expressly states that compounded medications are not FDA approved and do not undergo FDA review for safety, effectiveness or manufacturing quality before dispensing. FDA’s public guidance makes the same central distinction: approval belongs to a specific drug product, not to the clinic or pharmacy providing it. Nonapproval alone does not establish clinical inequivalence, but neither a named pharmacy nor a clinic certification substitutes for FDA approval of a particular preparation.
FDA recommends compounded drugs for patients whose medical needs cannot be met by an FDA-approved drug, with a prescription and a state-licensed pharmacy. The practical question for the consultation is how the proposed preparation fits the individual’s medical needs and what alternatives were considered. This recommendation should not be recast as a blanket legal conclusion about Slim. The reviewed documentation does not establish the precise product each patient receives or independently assess a particular preparation’s quality.
Delivery instructions matter if an injectable product is shipped. FDA explicitly recommends not using an injectable GLP-1 drug that arrives warm or with insufficient refrigeration, and contacting the provider or dispensing pharmacy to resolve the concern. FDA also reports measurement and administration errors with compounded medication, including some associated with hospitalization. Patients should obtain clarification from the prescriber or pharmacist rather than calculating instructions from a review. Our warm-delivery guide explains that specific FDA advice.
Follow-up is described, but response standards are not
Slim advertises ongoing follow-ups, aftercare, nutrition guidance and check-ins. Combined with its statement that McCullough handles follow-up for every patient, this suggests a continuity-based service rather than medication access alone. Nevertheless, the public material does not set a fixed check-in interval, identify a patient portal or promise a clinical response time. A personalized schedule may be useful, but patients still need to know when the next appointment is expected and how additional questions enter the clinical workflow.
For non-emergency treatment questions, the safety page directs patients to call (619) 765-4141 during business hours. The contact page also offers calling, texting and email, with front-desk assistance for questions and bookings. An email option is listed, but the consulted text did not expose a usable address. These administrative contact paths should not be interpreted as evidence of round-the-clock clinical coverage, secure medical messaging or a guaranteed same-day response.
Privacy practices reinforce the distinction between contacting reception and sharing medical details. Slim advises against sending sensitive health information through unsecured email or website forms. It says patient records and treatment information are covered by a separate Notice of Privacy Practices provided when someone becomes a patient. Marketing texts can be stopped by replying STOP; the policy says marketing consent is not required for treatment, while transactional messages connected to active care may continue.
Keep the GLP-1 plan distinct from the wider wellness menu
Slim is a broader wellness practice, not exclusively a GLP-1 service. Alongside semaglutide and tirzepatide, it advertises MIC plus B12 injections, either separately or alongside a GLP-1 program. Its other offerings include lab-based hormone replacement and testosterone replacement therapy, peptide protocols, customized IV infusions, NAD+ and B12 injections, Emerald Laser, Exion skin tightening and aesthetic care. Descriptions about energy, metabolism, recovery or vitality are the provider’s commercial positioning, not findings established by this review.
That wider menu makes an itemized plan particularly important. The tirzepatide advertisement expressly includes consultations and necessary supplies, but does not establish that these other services are included. Ask which elements are proposed for the GLP-1 plan, which are optional and which carry separate charges. Likewise, the inclusion of a 3D scan for in-clinic patients should not be treated as evidence that a particular outcome is guaranteed or that additional aesthetic treatment is medically necessary.
NIDDK describes weight-management medication as accompanying healthy eating and physical activity, with follow-up addressing tolerance and response rather than payment alone. It also notes that treatment duration depends on response and side effects and may involve long-term care. Those principles support asking Slim how progress will be assessed and how care changes will be discussed. They do not establish outcomes for this clinic, its compounded preparations or an individual patient, and they do not promise maintained results after stopping treatment.
Questions & answers
Will I see a physician at Slim Wellness Center?
The clinic says patient visits are conducted by Lyan Love McCullough, a nurse practitioner. It identifies Dr. Gidon Akler as the medical director who establishes and supervises protocols. Physician supervision therefore should not be read as a promise of a physician appointment. Ask who handles your consultation, subsequent clinical questions and coverage when your usual clinician is unavailable.
Can I use Slim’s telehealth tirzepatide program outside California?
The published offer is for California patients only; it does not document nationwide access. Even within California, the complete remote process is not explained. Confirm whether your proposed plan requires any clinic attendance, how the evaluation is conducted and whether medication is delivered or collected. The telehealth label and monthly price do not independently answer those questions.
Does the $179 or $200 monthly price include appointments?
Yes. Slim’s tirzepatide advertisement includes all prescribed dose levels, consultations and necessary supplies at $179/month in clinic or $200/month through telehealth, for California patients only. The in-clinic program also includes a 3D scan. Laboratory charges, shipping arrangements, the exact dispensed product and medication quantity are not established by that statement. Obtain an itemized description before committing.
Which pharmacy does Slim identify?
Slim names Integrity Compounding Pharmacy in Sandy Springs, Georgia, and publishes its telephone number as 404-815-1610. That is useful contact information, but this review did not independently verify licensing, certifications or the dispensing arrangement for an individual prescription. Ask your clinician to identify the actual product, dispensing pharmacy and contact for fulfillment questions before medication is prepared or sent.
How do I contact Slim between appointments?
For non-emergency treatment questions, Slim directs patients to (619) 765-4141 during business hours. Its contact page lists weekday office hours of 9:00 a.m. to 6:00 p.m., with weekends closed, and offers call, text and email contact for questions and bookings. No guaranteed clinical response time or after-hours arrangement is documented. Ask for the appropriate clinical contact process at your first visit.
Can I cancel after one month or receive a refund?
The reviewed documentation does not establish a minimum commitment, cancellation procedure, renewal arrangement or refund policy. The terms-of-service address displayed a privacy policy rather than those commercial conditions. A monthly advertised price is not proof of month-to-month cancellation rights, and cancellation would not itself establish a refund. Request the applicable written payment and cancellation terms before authorizing charges or choosing financing.
Our assessment
Slim Wellness Center documents several useful care-delivery anchors: a named treating nurse practitioner, a separate medical director, a physical clinic, published tirzepatide prices and a named pharmacy source. Its advertised continuity and included consultations make the service more identifiable than medication-only marketing. The limitations are operational: remote enrollment, exact product details, fulfillment, response standards and commercial exit terms remain insufficiently documented. Before paying, request a written plan identifying the medication, pharmacy, visit schedule, delivery or pickup arrangements, additional charges and cancellation rules. That would turn a reasonably clear clinic introduction into a more complete account of the care being purchased.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- Slim Wellness Center — medical weight loss ↗
- Slim Wellness Center — about us ↗
- Slim Wellness Center — privacy policy ↗
- Slim Wellness Center — safety info/glp1 ↗
- Slim Wellness Center — contact us ↗
- Slim Wellness Center — terms of service ↗
- Slim Wellness Center — official website ↗